Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations.

Tootee, Ali; Nikbin, Behrouz; Nasli Esfahani, Ensieh; Arjmand, Babak; Aghayan, Hamidreza; Qorbani, Mostafa; Ghahari, Aziz; Larijani, Bagher.

Afiliação

Tootee A; Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Nikbin B; Research Center of Molecular Immunology, Tehran University of Medical Sciences, Tehran, Iran.
Nasli Esfahani E; Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Arjmand B; Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Aghayan H; Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Qorbani M; Noncommunicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Ghahari A; BC Professional Firefighters' Burn and Wound Healing Research Laboratory, Department of Surgery, Plastic Surgery, University of British Columbia, Vancouver, Canada.
Larijani B; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Med J Islam Repub Iran ; 36: 34, 2022.

Article em En | MEDLINE | ID: mdl-36128298